Glukem Biocare Profile
Key Indicators
- Authorised Capital ₹ 5.15 Cr
as on 15-11-2024
- Paid Up Capital ₹ 9.90 M
as on 15-11-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.71 Cr
as on 15-11-2024
- Satisfied Charges ₹ 8.00 Cr
as on 15-11-2024
- Revenue 11.36%
(FY 2023)
- Profit 37.35%
(FY 2023)
- Ebitda 13.00%
(FY 2023)
- Net Worth 45.60%
(FY 2023)
- Total Assets -8.32%
(FY 2023)
About Glukem Biocare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.15 Cr and a paid-up capital of Rs 9.90 M.
The company currently has active open charges totaling ₹6.71 Cr. The company has closed loans amounting to ₹8.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Omkar Bommu, Rami Kolli, Varun Madupaduga, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24232TG2014PTC096067
- Company No.
096067
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Glukem Biocare?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Omkar Bommu  | Director | 05-May-2015 | Current |
| Rami Kolli | Director | 05-May-2015 | Current |
| Varun Madupaduga | Director | 20-Oct-2014 | Current |
| Hazra Kumar | Director | 20-Oct-2014 | Current |
| Ramanaiah Madupaduga | Director | 20-Oct-2014 | Current |
| Rakesh Chinnala | Director | 20-Oct-2014 | Current |
Financial Performance and Corporate Structure Insights of Glukem Biocare.
Glukem Biocare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.36% increase. The company also saw a substantial improvement in profitability, with a 37.35% increase in profit. The company's net worth Soared by an impressive increase of 45.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glukem Biocare?
In 2023, Glukem Biocare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Glukem Pharmaceuticals Private LimitedActive 15 years 10 monthsOmkar Bommu, Rami Kolli and 4 more are mutual person
- Vidur Human Care Private LimitedActive 6 years 9 months
Varun Madupaduga and Ramanaiah Madupaduga are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 25 Jan 2024 | ₹3.30 M | Open |
Axis Bank Limited Creation Date: 28 Oct 2022 | ₹9.45 M | Open |
Hdfc Bank Limited Creation Date: 06 Oct 2022 | ₹3.85 M | Open |
How Many Employees Work at Glukem Biocare?
Glukem Biocare has a workforce of 165 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glukem Biocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glukem Biocare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
